Monica Gordon-alonso
Scientist
Ludwig Center at Brussels
Ludwig Institute for Cancer Research
Belgium
Biography
My host laboratory has reported that treating human tumor-infiltrating lymphocytes with galectin antagonists or an anti-galectin-3 antibody boosts the secretion of cytokines upon stimulation. Extracellular galectins are involved in fibrosis, inflammation and cancer. I am examining in tumors whether galectins sequester glycosylated soluble factors at the extracellular matrix, such as interleukins and chemokines, impairing immune cell communication and recruitment. I am also assessing in different human inflammatory pathologies whether galectins affect immune dysfunction. I focus on pathologies where galectins could be found together with activated T lymphocytes, such as Crohn’s disease and arthritis. I will study how galectins regulate T cells, macrophages and fibroblasts in these diseases.
Research Interest
Tumor, immunology, cancer genetics
Publications
-
Petit AE, Demotte N, Scheid B, Wildmann C, Bigirimana R, Gordon-Alonso M, Carrasco J, Valitutti S, Godelaine D, van der Bruggen P. A major secretory defect of tumour-infiltrating T lymphocytes due to galectin impairing LFA-1-mediated synapse completion. Nature Communications. 2016 Jul 22;7:12242.